Two different researchers had reported an association between chronic fatigue and murine leukemia.

Two different researchers had reported an association between chronic fatigue and murine leukemia, but recent studies have not been able the results the results, leading scientists conclude that perhaps samples or equipment were contaminated.

The U.S. Presidential candidates U.S. Presidential candidates, in the combat against HIV / AIDS fightThe Global AIDS Alliance Fund and other groups are calling on U.S. Presidential candidates to sign a pledge to and the fight against HIV / AIDS in Germany to commit the world, the Keene Sentinel reports. The pledge also asks candidates to $ 50 billion, efforts efforts. According to the Sentinel, New Mexico Governor Bill Richardson is the only candidate who has signed the pledge. GAAF also has an online citizens promise that that calls on voters the the next U.S. President, created to create, support and fund a comprehensive plan to address the HIV / AIDS pandemic. .Hurt is the number one reason people leave, pain conditions a medical. There are estimated 72 million diagnosed chronic pain patients in the U.S. And EU, up to 30 % up to 30 % of the chronic pain patients received inadequate alleviating. New treatments consist of NSAID, selective COX – 2 inhibitors have, opioids and other analgesics added daily dosed daily and have various tolerability and safety, including the potential for abuse and addiction.

NFA be released at sites of tissue damage and inflammation, and plays a significant role in transferring of signals. Of pain in the CNS – The target for the treatment of chronic pain to potent long-lasting analgesia tolerable tolerable of patient not the potential to dependence and abuse continue, said John Leonard, Senior Vice President, Global Research and Development, Abbott. NGF blocking have shown the potential of all of these needs , making them. A promising treatment to chronic pain patients .. Abbott today a definitive agreement to Acquisition of the global rights for PanGenetics BV PG110 fully humanized antibodies to Nerve Growth Factor to acquire the expansion of business pain maintenance view portfolio and using its expert into biologic. PG110 is a novel organic in phase of I trial develop that targets NGF for treatment of chronic pain.

Both comments and pings are currently closed.

Comments are closed.

Powered by WordPress | Designed by: | Thanks to